Yeast Beta-glucan Market Size Worth $353.9 Million By 2030

Yeast Beta-glucan Market Growth & Trends

The global yeast beta-glucan market size is expected to reach USD 353.9 million by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.2% from 2022 to 2030. Immune-boosting properties associated with the product are likely to open numerous opportunities for the product growth in applications including food and beverage, pharmaceutical, and animal feed. Yeast beta-glucan is a polysaccharide that binds with immune cells and improves immune responses within the body. Yeast beta-glucan has been considered to be a valuable food ingredient owing to numerous health benefits such as its ability to reduce upper respiratory tract infections, help reduce cholesterol, and improve gut health.

Saccharomyces boulardii, which is a strain of Saccharomyces cerevisiae (baker's yeast), is effective for the treatment or prevention of various gastrointestinal (GI) problems, including a few different forms of diarrhea such as diarrhea associated with antibiotics, traveler’s diarrhea, and acute and persistent diarrhea. Yeast-based probiotic strain often finds application in animal feed owing to its low cost. The rise in upper respiratory tract infections, which reached 17.2 billion in 2019 in the U.S., has increased the emphasis on immunity-boosting medication and supplements such as yeast beta-glucan in the U.S., propelling the growth of the market in the country.

Furthermore, on account of the COVID-19 pandemic, the consumers are becoming more concerned about their health and immunity, which is likely to have a positive impact on the industry growth. The majority of the players operating in the market are focusing more on their supply chain and global distribution network in order to meet the increasing product demand in various application industries across the globe.

 Request a free sample copy or view report summary: Yeast Beta-glucan Market Report

Yeast Beta-glucan Market Report Highlights

• The animal feed application segment is expected to expand at the fastest CAGR of 9.0% in terms of revenue over the forecast period on account of its ability to enhance growth and immunity

• The food and beverages application segment held the largest revenue share of over 30.0% in 2021 and is projected to maintain its lead throughout the forecast period owing to rapid R&D and production-related investments in the sector

• The personal care and cosmetics application segment is expected to expand at a volume-based CAGR of 8.1% from 2022 to 2030 owing to its rising demand for manufacturing toners, conditioners, and skin moisturizers

• The market is driven by strong application-based research and development, thus key players operating in the global market such as Cargill, Incorporated, and Lesaffre are expected to put more emphasis on R&D activities

Yeast Beta-glucan Market Segmentation

Grand View Research has segmented the global yeast beta-glucan market on the basis of application and region:

Yeast Beta-glucan Application Outlook (Volume, Tons; Revenue, USD Million, 2017 - 2030)

• Food & Beverages

• Personal Care & Cosmetics

• Pharmaceuticals

• Animal Feed

• Others

Yeast Beta-glucan Regional Outlook (Volume, Tons; Revenue, USD Million, 2017 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

• Asia Pacific

  • China

  • India

  • Japan

• Central & South America

  • Brazil

• Middle East & Africa

  • South Africa

List of Key Players of Yeast Beta-glucan Market

• Cargill, Incorporated

• Lesaffre Human Care

• EMD Millipore

• Biorigin

• Kerry Group plc

• Lallemand, Inc.

• Specialty Biotech Co., Ltd.

• Van Wankum Ingredients

• Angel Yeast Co., Ltd.

• Leiber